EUCTR2011-004995-13-NL进行中（未招募）不适用
Endovascular renal sympathetic denervation versus spironolactone for treatment-resistant hypertension: a randomized, multicentric study - RRSS
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- Erasmus MC
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age between 18 and 75 yrs
- •Treatment-reistant hypertension
- •Willingness to give written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 90
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 40
排除标准
- •Secondary forms of hypertension
- •Renal arteries not accessible to intervention
- •Suboptimal dosing of anthypertensive medication
- •White coat hypertension
- •Renal insufficiency (GFR < 45 ml/min
研究者
相似试验
已完成
不适用
Endovascular renal sympathetic denervation versus spironolactone for treatment-resistant hypertension: a randomized, multicentric studyhypertensieHigh blood pressureHypertensionNL-OMON37880Erasmus MC, Universitair Medisch Centrum Rotterdam130
招募中
不适用
Renal denervation to improve heart failureSystolic heart failureNL-OMON25325Erasmus Medical CenterRotterdam, the Netherlands70
招募中
不适用
Endovascular Renal Sympathetic Denervation using the Boston Scientific Vessix V2 renal denervation system to Improve Heart Failure10019280Heart failureNL-OMON40689Erasmus MC, Universitair Medisch Centrum Rotterdam70
招募中
不适用
Comparison of renal sympathetic denervation with spironolactone in patients with still a high blood pressure despite the use of 3 different antihypertensive agents.Hypertension, Renal sympathetic denervation, Sprionolactone. Hypertensie, Renale sympathische denervatie, spironolactonNL-OMON26106Erasmus MC: Department of Radiology120
进行中（未招募）
不适用
/AEUCTR2012-001066-14-ESConsorci Mar Parc de salut de Barcelona ( Parc de Salut Mar)